These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34208833)

  • 1. Metabolic Syndrome: Is It Time to Add the Central Nervous System?
    Rojas M; Chávez-Castillo M; Pirela D; Parra H; Nava M; Chacín M; Angarita L; Añez R; Salazar J; Ortiz R; Durán Agüero S; Gravini-Donado M; Bermúdez V; Díaz-Camargo E
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34208833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome, hypertension, and nervous system injury: Epidemiological correlates.
    Ricci G; Pirillo I; Tomassoni D; Sirignano A; Grappasonni I
    Clin Exp Hypertens; 2017; 39(1):8-16. PubMed ID: 28071980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer's disease rat model.
    Ivanova N; Liu Q; Agca C; Agca Y; Noble EG; Whitehead SN; Cechetto DF
    J Neuroinflammation; 2020 Jan; 17(1):29. PubMed ID: 31964387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic pathways of cognitive dysfunction and dementia in metabolic syndrome.
    Borshchev YY; Uspensky YP; Galagudza MM
    Life Sci; 2019 Nov; 237():116932. PubMed ID: 31606384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome, mild cognitive impairment and Alzheimer's disease--the emerging role of systemic low-grade inflammation and adiposity.
    Misiak B; Leszek J; Kiejna A
    Brain Res Bull; 2012 Nov; 89(3-4):144-9. PubMed ID: 22921944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Plasma Resistin Levels Portend the Insulin Resistance-Associated Susceptibility to Early Cognitive Decline in Patients with Type 2 Diabetes Mellitus.
    Wang C; Huang X; Tian S; Huang R; Guo D; Lin H; Wang J; Wang S
    J Alzheimers Dis; 2020; 75(3):807-815. PubMed ID: 32333593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer's disease: A case study.
    Morrill SJ; Gibas KJ
    Diabetes Metab Syndr; 2019; 13(2):1187-1191. PubMed ID: 31336463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive definition for metabolic syndrome.
    Huang PL
    Dis Model Mech; 2009; 2(5-6):231-7. PubMed ID: 19407331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationships Between Components of Metabolic Syndrome and Mild Cognitive Impairment Subtypes: A Cross-Sectional Study of Japanese Older Adults.
    Bae S; Shimada H; Lee S; Makizako H; Lee S; Harada K; Doi T; Tsutsumimoto K; Hotta R; Nakakubo S; Park H; Suzuki T
    J Alzheimers Dis; 2017; 60(3):913-921. PubMed ID: 28922149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome, mild cognitive impairment, and dementia.
    Panza F; Frisardi V; Seripa D; Imbimbo BP; Sancarlo D; D'Onofrio G; Addante F; Paris F; Pilotto A; Solfrizzi V
    Curr Alzheimer Res; 2011 Aug; 8(5):492-509. PubMed ID: 21605050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies.
    Atti AR; Valente S; Iodice A; Caramella I; Ferrari B; Albert U; Mandelli L; De Ronchi D
    Am J Geriatr Psychiatry; 2019 Jun; 27(6):625-637. PubMed ID: 30917904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of mild cognitive impairment and metabolic syndrome in patients with hypertension.
    Mehra A; Suri V; Kumari S; Avasthi A; Grover S
    Asian J Psychiatr; 2020 Oct; 53():102185. PubMed ID: 32540752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Bonfill Cosp X; Flicker L
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012216. PubMed ID: 29164603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging.
    Alfaro FJ; Gavrieli A; Saade-Lemus P; Lioutas VA; Upadhyay J; Novak V
    Metabolism; 2018 Jan; 78():52-68. PubMed ID: 28920863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysis.
    Pal K; Mukadam N; Petersen I; Cooper C
    Soc Psychiatry Psychiatr Epidemiol; 2018 Nov; 53(11):1149-1160. PubMed ID: 30182156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer's disease: an interdisciplinary perspective.
    Larouche E; Hudon C; Goulet S
    Behav Brain Res; 2015 Jan; 276():199-212. PubMed ID: 24893317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer's disease].
    Allegri RF; Russo MJ; Kremer J; Taragano FE; Brusco I; Ollari JA; Serrano CM; Sarasola D; Demey I; Arizaga RL; Bagnati P
    Vertex; 2012; 23(101):5-15. PubMed ID: 22880190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.